Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04928248 · ClinicalTrials.gov registry record · NA

Design, Implementation and Evaluation of Scalable Decision Support for Diabetes Care

A NA study, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
25,915
Enrollment target

NCT04928248: Completed NA study, sponsored by University of Utah.

NCT04928248 is a NA study that has completed, run by University of Utah. The registered enrollment target is 25,915 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1747% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04928248, a NA study, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
25,915 participants
Enrollment target

Study Summary

Diabetes is a significant medical problem in the United States and across the world. Despite significant progress in understanding how to better manage diabetes, there is oftentimes still uncertainty in the optimal management strategy for a specific patient. As a result, providers and patients must often use a trial-and-error approach to identify an effective treatment regimen. The project team has previously developed a Diabetes Dashboard that summarizes relevant patient information (e.g., medication history and recent hemoglobin A1c trend). This dashboard allows a clinician to select a target hemoglobin A1c level for the patient in 3 or 6 months, then compare and contrast different options for treatment, including weight loss and the use of different medication regimens. Included in this comparison are known benefits and side effects, as well as the likely chances of achieving the treatment target given the experience of past, similar patients. The Diabetes Dashboard is already available as an optional tab in the EHR system. The project team has also previously developed the Disease Manager App for evidence-based chronic disease management and health maintenance. The Disease Manger Application is fully integrated with the EHR, and it provides care guidance via individual chronic disease modules as well as a unified module that encompasses all relevant modules for chronic diseases and health maintenance. The initial modules that have been developed are for chronic obstructive pulmonary disease, hypertension, diabetes mellitus, and health maintenance. The objective of this research is to evaluate the Diabetes Dashboard integrated with the Disease Manager App. The Intervention consists of the diabetes module of the Disease Manager App, which incorporates content from the Diabetes Dashboard for pharmacotherapy prediction and provides a link to the Diabetes Dashboard.

Primary Outcome

Each patient's HbA1c level will be estimated for day 15 of each month, calculated as follows. If a value exists for that date, use that. Otherwise, estimate the value on that date based on the values immediately before and after that date.

Interventions

  • OTHER Diabetes Dashboard integrated with Disease Manager App

Trial Details

FieldValue
Enrollment Target 25,915 participants
Start Date 2021-09-23
Est. Completion 2022-11-01
Phase NA
University of Utah

818 total trials

What the finished NCT04928248 record still lists

NCT04928248 is an interventional study that assigns participants to a tested intervention. Its 25,915 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1747% higher).

The record links to 0 conditions, and to 1 intervention - of which Diabetes Dashboard integrated with Disease Manager App is the first listed.

NCT04928248 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04928248 about?

NCT04928248 is a clinical study titled "Design, Implementation and Evaluation of Scalable Decision Support for Diabetes Care". Diabetes is a significant medical problem in the United States and across the world. Despite significant progress in understanding how to better manage diabetes, there is oftentimes still uncertainty in the optimal management strategy for a specific patient. As a result, providers and patients must ...

What is the current status of trial NCT04928248?

This trial is currently completed. It is a NA study. The enrollment target is 25,915 participants. The study started on 2021-09-23. Estimated completion is 2022-11-01.

What interventions are being tested in trial NCT04928248?

The interventions under investigation include: Diabetes Dashboard integrated with Disease Manager App (OTHER).

Who is sponsoring clinical trial NCT04928248?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04928248's enrollment target sits among peer trials

25,915 9th of 2000 higher than 1,992 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07300839 · 25,500 participants · Phase 3

    A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

  • NCT03175302 · 25,240 participants

    PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing

  • NCT04595201 · 25,000 participants

    Clinical Follow-up of Pregnant Subjects Undergoing NIPT

  • NCT04994015 · 25,000 participants

    Parkinson's Foundation PD GENEration Genetic Registry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04928248, the US trial registry maintained by the National Library of Medicine. NCT04928248 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.